ArticleInternational journal of surgery case reports2026
Diffuse large B-cell lymphoma as a rare cause of small bowel obstruction: case report and literature review.
Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most frequent subtype of non-Hodgkin lymphoma, representing about 30% of cases. Extranodal involvement occurs in 10-20%, most commonly in the stomach. Small bowel localization is less frequent and can occasionally present as small bowel obstruction (SBO), a challenging and unusual initial manifestation. Case Presentation: A 65-year-old woman with no relevant medical history was admitted for acute abdominal pain, vomiting, and distension evolving for 48 h. Clinical examination showed abdominal tympany with no palpable masses and normal laboratory tests. Abdominal computed tomography revealed marked small bowel dilatation with a thickened, stenosing ileal segment. Conservative treatment was initiated, but persistent symptoms prompted surgery. Exploratory laparotomy revealed a 4 cm ileal lesion located 3 m from the duodenojejunal junction. Segmental resection and side-to-side mechanical anastomosis were performed. Histopathology showed a transmural proliferation of large atypical lymphoid cells. Immunohistochemistry demonstrated CD20 positivity and negativity for CD10 and Bcl-6, confirming a diagnosis of non-germinal center DLBCL. The postoperative course was uneventful and the patient remained disease-free at 8-month follow-up after completing R-CHOP chemotherapy. Discussion: DLBCL of the small intestine may mimic common causes of SBO, delaying diagnosis. Cross-sectional imaging is helpful to identify the obstruction, but histological examination remains essential. Surgical resection is crucial both for symptom control and for establishing the diagnosis, after which systemic chemotherapy, usually R-CHOP, is indicated. Conclusion: Although rare, DLBCL should be considered as a differential diagnosis in unexplained SBO. Early recognition and a multidisciplinary management strategy improve prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.